Skip to content
MyStudyTimes.com
Provider Reviews

Wellmedr vs Oak Longevity: pricing, review speed, and plan differences

Rate this post

Comparing Wellmedr vs Oak Longevity? Quick verdict: Wellmedr leans on lower advertised starting prices and lifetime locked pricing while Oak Longevity emphasizes a one-price-for-all-dosages model, no subscription, and free coaching.

See Wellmedr plans starting at $89/mo

How they differ at a glance

The comparison between Wellmedr and Oak Longevity centers on five clear differences supported by the sources: starting price and plan types, pricing model and subscriptions, shipping and guarantee terms, clinical review flow, and inclusions such as coaching or locked pricing. Each provider offers compounded GLP-1 options and notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

1) Starting price and plan structure

Wellmedr advertises GLP-1 plans starting at $89/month, with semaglutide and tirzepatide options and specific monthly and 1-year plan language captured on their landing page. Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month. Both providers present monthly pricing, but the numeric starting points are different in the sourced material.

Compare Wellmedr pricing and plans

2) Pricing model and commitments

Wellmedr promotes lifetime locked-in pricing and states no dose-based price increases, plus promotional claims captured on the landing page such as a Labor Day Sale and new customer offers. Oak Longevity markets one flat price for all dosages and explicitly states no subscriptions, no membership fees, and no hidden costs; Oak bills monthly on a non-recurring basis so patients are not auto charged and choose to renew each month. Oak also notes three-month prescriptions are billed upfront and no refunds are available after physician approval and once medication has shipped.

3) Shipping, guarantees, and refunds

Wellmedr highlights same-day review plus free overnight shipping in captured bullets and includes a money-back guarantee claim on the landing page stating a 90-day refund condition in promotional text. Oak Longevity offers free shipping with tracking and writes that most patients receive medication within a few days of approval; Oak also states no refunds are available after physician approval and once medication has shipped.

View Oak Longevity shipping and refund terms

4) Clinical review and access

Oak Longevity specifies an asynchronous clinical review without a video call: you complete an online health questionnaire and a licensed physician reviews your information. Oak also notes board-certified physicians in your state review every case and same-day approval is available for qualifying patients. Wellmedr states all treatment plans require medical evaluation and clinician approval and advertises same-day review in captured landing-page evidence; the wellmedr content also emphasizes eligibility checks and that treatment is available only when a licensed clinician determines it is medically appropriate.

5) Added features and eligibility notes

Oak includes free health coaching with every plan and notes patients with BMI below 20 or below 22 without comorbidities may not qualify, and other explicit eligibility constraints are captured. Wellmedr focuses on lifetime locked pricing and promotional offers; both providers include regulatory notices that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

Side-by-side comparison table

Criteria Wellmedr Oak Longevity
Semaglutide starting price Starting at $89/mo Starting at $133/mo
Tirzepatide starting price Starting at $89/mo (listed for tirzepatide plans) Starting at $199/mo
Pricing model Lifetime locked-in pricing; no dose-based price increases One flat price for all dosages; no subscriptions
Subscriptions Monthly plans with promotional 1-year language captured No subscription; billed monthly non-recurring or 3-month upfront
Shipping and guarantees Same-day review + free overnight shipping; money-back claim on landing page Free shipping with tracking; no refunds after approval and shipment
Clinical review All plans require clinician approval; same-day review claimed Asynchronous review from licensed physicians; same-day approval for qualifying patients

What the sources say about safety and regulation

Both providers explicitly include regulatory notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Wellmedr additionally lists required safety warnings about GLP-1 risks such as thyroid C-cell tumors and medullary thyroid carcinoma and advises seeking immediate care for symptoms like neck swelling or trouble swallowing. Oak also warns results vary by individual and lists age and BMI-related eligibility constraints in captured content.

Explore Oak Longevity plans and coaching

Final comparison and who should choose which

In a direct Wellmedr vs Oak Longevity comparison, choose based on the priorities highlighted in the sources: Wellmedr emphasizes lower advertised starting prices, lifetime locked pricing, and same-day review with promotional refund language. Oak Longevity emphasizes a simple one-price-for-all-dosages model, no subscriptions, free health coaching, free shipping with tracking, and an asynchronous clinical review process.

Choose Wellmedr if you prioritize lower advertised starting pricing and the lifetime locked pricing or the specific promotional guarantees described on their landing page. Choose Oak Longevity if you want a one-price-for-all-dosages approach, no subscription model, included health coaching, and free shipping with asynchronous physician review.

Ready to Compare GLP-1, NAD+, TRT Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.